Introduction
Double-J stenting is a common procedure in urology but the stents are poorly tolerated. Ureteral obstruction caused by benign or malignant extrinsic compression is a challenge in the management of stent patency. Obstruction is a significant cause of morbidity and mortality from renal failure. Novel concepts to treat and prevent stent-related symptoms are mandatory. 1 Alternative options for decompression include tandem ureteral stents and metallic stents.
But the amount of material in the bladder may severely impair the quality of life of patients and induce an additional suffering to the disease.
Case presentation
A 75-year-old patient was treated for oesophagus cancer with surgery, chemotherapy, radiotherapy, and now immunotherapy.
Ureteric stents insertion was performed for malignant ureteral obstruction with renal failure. Ureteral duplicity requires double stent insertion at the left side (Fig. 1A) .
After recurrent stent obstruction, stent replacement with various tumor stents was attempted every month while 6 months. Despite six different procedures, the three stents failed to maintain kidney function (Serum creatinine: 2.7 mg/dL; creatinine clearance: 10.0 mL/min). Moreover, indwelling stents impaired the quality of life with severe incontinence. In this case, indwelling bladder stent was necessary.
Following these failures, a last procedure was attempted with a new stent design. The patient was fitted with tandem ureteral stent on both sides (Fig. 1B) . In addition, the stent was modified and the major characteristic was in the replacement of the bladder part of the doublepigtail stent with a nonrefluxing silicone end piece (Fig. 1C) . The human use of the silicone end piece was approved by French Ethical Committee and National Medicine Safety Agency (CPP 17-VOGT-01 and 2017-A00205-48, respectively). Patient agreed to be fitted with the silicone end piece. A polyurethane double-pigtail tumor stent 8F was sectioned perpendicularly, ensuring that the stent remains long enough to descend at the ureteral meatus. A silicone end piece was embedded at the bottom of the sectioned stent.
After this procedure, renal function was improved with serum creatinine and creatinine clearance at 1.0 mg/dL and 27.0 mL/min, respectively. Bladder stent has been removed.
In few weeks, health-related quality of life was improved. At 3-month post-placement, patency has been confirmed by endoscopy, retrograde ureterography and, serum creatinine (0.9 mg/dL). No dislodgment and no calcification were encountered.
Discussion
The perfect ureteral stent should demonstrate optimal patency and should be well tolerated by the patient. 2 With a ureteral obstruction, stent replacement is required and quality of life is negatively affected by the need for frequent stent changes. 3 Moreover, kidney failure is a barrier to chemotherapy. 
T
Tandem stents have developed as alternatives to single ureteral stents, while maintaining internal drainage. It is believed that tandem better resist obstruction by providing a space in between the two stents that is difficult to compress. 4 However, the presence of 4 loops may not be well tolerated and impaired the quality of life with severe incontinence. It has been suggested that pelvic symptoms could be decreased by reducing the amount of material in the bladder. 5 The replacement of the bladder loop with a small smooth silicone end piece results in the presence of only tiny amounts of material in the bladder.
Conclusion
In this case presentation, the design of the silicone end piece demonstrates the feasibility of the procedure. The better tolerance of the silicone end piece may lead to largely use tandem ureteral stents and, thus prevent renal failure. This new stent currently under prospective evaluation with tolerance questionnaire has demonstrated quite promising results in 10 patients. 
